Kush Parmar, M.D., Ph.D., is a Managing Partner at 5AM Ventures where he invests in seed and Series A stage startups across biotech and life sciences in the USA. He serves on the boards of Entrada Therapeutics (Chairman), Ensoma, and Rallybio, and has invested in companies like Entrada Therapeutics, Ensoma, Rallybio, Homology Medicines, and Audentes Therapeutics. Previously, he was the Founding CEO and Chairman of Homology Medicines and co-founded Immuneel Therapeutics. He was educated at Princeton University, Harvard Medical School/MIT (HST), and Harvard University, and lives in Boston, Massachusetts.
Kush Parmar, M.D., Ph.D., Managing Partner @ 5AM. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Kush Parmar, M.D., Ph.D. from 5AM Ventures. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Kush
Map your path to Kush instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Kush
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.